Micronized Progesterone vs Progesterone Cream: What the Trials Actually Tested
Body · The Reading Room · Evidence review · 8 min read · Two small trials of the cream disagree with each other. The pill has decades of data. Here is what each one was actually tested for
Reviewed against the published work of John A. Eden, MB BS, MD, FRCOG, FRANZCOG, Conjoint Associate Professor in Reproductive Endocrinology at UNSW Sydney, director of the Sydney Menopause Centre and Natural Therapies Unit at the Royal Hospital for Women, and co-author of a randomized trial of progesterone cream. UNSW research profile · UNSW staff page · the trial on PubMed
“Natural progesterone” describes two very different products. One has been tested against the question that matters most. The other mostly has not.
A friend swears by it. Quarter of a teaspoon on the inner arm at night, and she says the 3 a.m. wake-ups stopped within a month. The jar is on the counter at the health store, next to the magnesium, no prescription needed.
Your doctor, meanwhile, mentioned something called micronized progesterone, which also sounds natural, but comes as a capsule, from a pharmacy, with a leaflet.
Readers searching micronized progesterone mostly want to know one thing: is the jar a gentler version of the prescription, or something else entirely? This review looks at what the trials tested. Informational, not medical advice. The findings belong to the researchers named below; the plain-English reading, and any error in it, belongs to Blue Leaf Journal.
The short answer: they are not interchangeable. Progesterone cream has been tested in two small randomized trials for hot flashes, and they disagree: one found 83 percent of users improved against 19 percent on placebo,¹ the other found no difference from placebo.² Neither the over-the-counter nor the compounded versions are FDA-approved, and a clinical review notes compounded progesterone is not recommended because of insufficient evidence that it protects the uterine lining.³ Oral micronized progesterone is an approved drug, and in the large PEPI trial it protected the lining when taken alongside estrogen.4 For a woman with a uterus using estrogen, that difference is the one that matters.
The skim version
- Trial one (1999): 102 women, 20 mg cream daily for a year. Hot flashes improved or resolved in 83 percent on cream versus 19 percent on placebo. No effect on bone density.¹
- Trial two (2003): 80 women, 32 mg cream daily for 12 weeks. No significant difference from placebo in menopausal symptoms, although blood progesterone rose.²
- Endometrial protection: compounded progesterone is not recommended because the evidence that it protects the uterine lining is insufficient.³
- Micronized progesterone, 200 mg for 12 days a month alongside estrogen, reduced endometrial hyperplasia compared with estrogen alone in the 875-woman PEPI trial.4
- In perimenopause, a 189-woman trial of oral micronized progesterone found improved sleep and fewer perceived night sweats, but no significant change in its main hot flash score.5
- Evidence grade for the cream: Contested.
In this article: What progesterone cream is · What the two trials found · Micronized progesterone · Cream versus capsule · How strong is this evidence? · The one move · FAQ
What is progesterone cream, and is it the same as prescription progesterone?
Chemically, both usually contain progesterone identical to the hormone the ovaries make. The difference is everything around the molecule: how much reaches the bloodstream, how consistent each dose is, and what it has been tested to do.
Progesterone creams are sold over the counter or made up by compounding pharmacies. Neither route is an FDA-approved progesterone product for menopause, which means dose, absorption and purity are not held to the standard an approved drug must meet. A clinical review on the NCBI Bookshelf is direct about the consequence: compounded progesterone is not recommended, because the evidence that it protects the lining of the uterus is insufficient.³
Micronized progesterone is the same hormone processed into very fine particles so it can be absorbed when swallowed. Taken as a capsule, it is an approved drug and has been studied in large trials, which is why clinicians use it in hormone therapy.³4
Does progesterone cream work for hot flashes?
The honest answer is that two trials asked, and they came back with different answers.
The first, led by Helen Leonetti and published in Obstetrics and Gynecology in 1999, gave 102 postmenopausal women either a quarter teaspoon of progesterone cream (20 mg) or placebo daily for a year. Among those who reported on hot flashes, 25 of 30 women on the cream, 83 percent, noted improvement or resolution, against 5 of 26 on placebo, 19 percent. The cream did not change bone density, which was the trial’s other question.¹
The second, by Barry Wren, John Eden and colleagues in Sydney, published in Menopause in 2003, gave 80 postmenopausal women 32 mg of cream or placebo daily for 12 weeks. Blood progesterone levels rose in the treatment group. Symptoms did not: the trial found no significant decrease in menopausal symptoms compared with placebo, and the authors concluded the cream, at that dose, did not improve symptoms.²
Two small trials, different doses, different durations, opposite conclusions. That is not a settled evidence base in either direction, and anyone describing progesterone cream as proven, or as proven useless, is claiming more than the studies show.
What the research found
The trial. Wren, Champion, Willetts, Manga and Eden, “Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women”, Menopause, 2003.
The finding. In 80 postmenopausal women with a mean age of 54, 32 mg of progesterone cream daily for 12 weeks raised serum progesterone but produced no significant decrease in menopausal symptoms compared with placebo.²
The limitation: 80 women and 12 weeks is a small, short trial, and it tested one dose of one cream. The earlier Leonetti trial, also small, found the opposite for hot flashes over a year at a lower dose.¹ Neither trial tested whether a cream protects the uterine lining in women also taking estrogen.
If the jar on the counter is one of several things you have been trying on your own while nobody looks at the whole picture, it may help to lay the whole picture out first. Start here.
The researcher behind this review
John A. Eden, MB BS, MD, FRCOG, FRANZCOG
Conjoint Associate Professor in Reproductive Endocrinology at UNSW Sydney. At the Royal Hospital for Women in Sydney he directs the Sydney Menopause Centre, the Natural Therapies Unit and the Barbara Gross Research Unit. His research covers menopause, phytoestrogens and herbal and natural therapies, which makes his involvement in a negative trial of a popular natural product worth noting.
What was read: Wren, B. G., Eden, J. A., et al., Menopause, 2003.²
Where to follow his work: UNSW research profile · UNSW staff page · ResearchGate · Healthed expert page · HealthShare profile
What is micronized progesterone used for?
Its main job in menopause care is protecting the uterus.
Estrogen on its own stimulates the lining of the uterus, and over time that can lead to overgrowth. The PEPI trial, which enrolled 875 postmenopausal women for three years, tested this directly. Women on estrogen alone had significantly more adenomatous and atypical hyperplasia, the kinds of overgrowth that matter, and more hysterectomies. Adding a progestogen, including micronized progesterone at 200 mg for 12 days a month, substantially reduced that risk.4
That is why a woman with a uterus who takes estrogen is prescribed a progestogen too, and why the NCBI clinical review describes oral micronized progesterone, 100 to 200 mg nightly, as an excellent starting point, with 200 mg daily adequate for a standard estradiol patch dose.³
There is also growing interest in progesterone on its own for perimenopausal symptoms. A Canada-wide trial led by Jerilynn Prior gave 189 perimenopausal women 300 mg of oral micronized progesterone or placebo at bedtime for three months. Its main hot flash and night sweat score did not differ significantly, though the trial was underpowered and could not rule out a small benefit. Sleep quality and perceived night sweats did improve significantly.5
Micronized progesterone vs progesterone cream
| Question | Progesterone cream | Oral micronized progesterone |
|---|---|---|
| Regulated as an approved drug? | No; over the counter or compounded | Yes |
| Hot flashes | Two small trials disagree¹² | Main score not significant in one perimenopause trial; sleep and night sweats improved5 |
| Protects the uterine lining with estrogen? | Not established; compounded use not recommended³ | Yes, in the PEPI trial4 |
| Bone density | No effect in the 1999 trial¹ | Not the question these trials tested |
| Limitation | Small, short, inconsistent trials; variable products | Perimenopause trial underpowered; PEPI used one estrogen type |
How strong is this evidence?
Contested, for the cream
Two small randomized trials of progesterone cream for hot flashes point in opposite directions, and there is insufficient evidence that it protects the uterine lining.¹²³ The evidence for oral micronized progesterone protecting the lining alongside estrogen is considerably firmer, coming from a large randomized trial.4 The two should not be treated as the same thing in different packaging.
Who else has measured this
Helen B. Leonetti, MD, was first author of the 1999 randomized trial in Obstetrics and Gynecology that found hot flashes improved in 83 percent of women using progesterone cream against 19 percent on placebo.¹
the 1999 trial on PubMed · summary in American Family Physician
Barry G. Wren, MD, was first author of the 2003 Sydney trial that found no significant symptom benefit from progesterone cream compared with placebo.²
the 2003 trial on PubMed · summary in The Journal of Family Practice
Jerilynn C. Prior, MD, FRCPC, Professor of Endocrinology and Metabolism at the University of British Columbia and founder of the Centre for Menstrual Cycle and Ovulation Research, led the Canada-wide trial of oral micronized progesterone for perimenopausal night sweats and hot flashes.5
CeMCOR biography · Wikipedia · the 2023 trial in Scientific Reports
The same molecule. Not the same evidence.
When this belongs with a doctor
If you have a uterus and use any estrogen, including an estrogen cream or gel bought online, do not rely on a progesterone cream to protect the lining; talk to a prescriber about an approved progestogen. See a clinician promptly for any bleeding after twelve months without a period, or new, heavy or irregular bleeding while using any hormone product.
The sentence to take with you: “I have been using, or thinking about using, a progesterone cream for my symptoms. Is that doing anything for my uterus if I am also on estrogen, and would micronized progesterone be a better fit for me?”
The one move: read the jar, then say what is in it
Before the next appointment, take a photo of the label on anything hormonal in the house. The cream, the gel, the supplement that says it balances hormones.
Show it to your clinician and name what else you use, especially any estrogen. This is the information that changes the advice: the risk the evidence identifies is estrogen without adequate progestogen protection, and a cream that has not been shown to provide that protection can create a false sense of cover.³4
It takes one minute, and it turns a private experiment into a decision you have made with full information.
Common questions
Does progesterone cream work?
The evidence is mixed. A 1999 trial found hot flashes improved in 83 percent of women on 20 mg cream against 19 percent on placebo; a 2003 trial of 32 mg cream found no significant difference from placebo.¹²
Is progesterone cream the same as micronized progesterone?
No. Both usually contain progesterone, but oral micronized progesterone is an approved drug shown in the PEPI trial to protect the uterine lining alongside estrogen.4 Compounded progesterone is not recommended because evidence of endometrial protection is insufficient.³
What is micronized progesterone used for?
Mainly to protect the uterus in women with a uterus who take estrogen. In the PEPI trial, 200 mg for 12 days a month reduced endometrial hyperplasia compared with estrogen alone.4
Can progesterone cream protect the uterus if I use estrogen?
That has not been established. A clinical review states compounded progesterone is not recommended for this purpose because of insufficient evidence of endometrial protection.³ Speak to a prescriber about an approved option.
Does progesterone help with sleep in perimenopause?
In a 189-woman trial, 300 mg of oral micronized progesterone at bedtime significantly improved sleep quality and perceived night sweats, although the main hot flash score did not change significantly.5
The one move
Photograph the label on every hormonal product you use, including any estrogen, and show your clinician. A cream that has not been shown to protect the uterine lining should not be your only cover.
If you have been assembling your own solutions one jar at a time, seeing everything that is going on in one place may be the better starting point. Start here.
The word natural is on both. Only one of them was tested for the job you most need done.
Related reading: a closer look at whether progesterone cream works, what the term estrogen dominance gets right and wrong, what regulated hormone therapy is, and every evidence-backed option for hot flashes.
On the researchers. John Eden and Barry Wren are cited for the 2003 trial, Helen Leonetti for the 1999 trial, and Jerilynn Prior for the 2023 perimenopause trial. None of them is your clinician, and none of the trials was large enough to settle the questions this review describes.
Sourcing, disclosure and disclaimers
This is not medical advice. Blue Leaf Journal publishes general information for a general readership. Nothing here is a diagnosis, a treatment recommendation, or a substitute for care from a clinician who knows your history. Informational, not medical advice: see your clinician.
We are not clinicians. Blue Leaf Journal is an independent publication and its bylines carry no medical or academic credential. We read published research and translate it. The findings belong to the researchers and institutions named and linked above; the plain-English rendering is ours, and so is any error in it.
No affiliation and no endorsement. Blue Leaf Journal is not affiliated with John A. Eden, Barry G. Wren, Helen B. Leonetti, Jerilynn C. Prior, UNSW Sydney, the Royal Hospital for Women, the University of British Columbia, the Centre for Menstrual Cycle and Ovulation Research or the PEPI Trial investigators. None of them has reviewed, approved or endorsed this article, and none of them is responsible for it.
No commercial relationship. Nobody named above paid for or was paid for this coverage. There are no affiliate links, no sponsored placements and no product recommendations in this article.
How this was checked. Every figure above was checked against the cited source on 16 September 2026, and each source is linked below. If you find something we have got wrong, write to norawhitfield@blueleafjournal.com and we will correct it and say that we did.
References
1. Leonetti, H. B., Longo, S., Anasti, J. N. “Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss.” Obstetrics and Gynecology, 1999. PubMed · American Family Physician summary
2. Wren, B. G., Champion, S. M., Willetts, K., Manga, R. Z., Eden, J. A. “Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women.” Menopause, 2003, 10:13–18. PubMed · Journal of Family Practice summary
3. “Hormone Replacement Therapy.” StatPearls, NCBI Bookshelf. ncbi.nlm.nih.gov
4. The Writing Group for the PEPI Trial. “Effects of hormone replacement therapy on endometrial histology in postmenopausal women.” JAMA, 1996. PubMed · American College of Cardiology trial summary
5. Prior, J. C., et al. “Oral micronized progesterone for perimenopausal night sweats and hot flushes: a Phase III Canada-wide randomized placebo-controlled 4 month trial.” Scientific Reports, 2023. nature.com, open access
Keep reading
Miriam Alderton is Research Editor at Blue Leaf Journal. She reads the methods section first and the abstract last, and every figure in this piece is linked to its source below.
Written by Miriam Alderton for Blue Leaf Journal. Updated: 16 September 2026.
